Partners and Alerts: A Study of Social Forces in Medication Adherence
NCT ID: NCT01890018
Last Updated: 2017-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
178 participants
INTERVENTIONAL
2013-06-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is designed to examine the existence of strong associations between social networks and health behavior. This study intends to demonstrate that social forces are particularly effective at building enduring habits for healthy behavior, specifically adherence to statin medication for this study. The investigators believe the improved medication adherence will result in fewer additional vascular events, following the most recent of these events, and will result in fewer patient hospitalizations. The investigators will leverage insights from the fields of social comparison (being provided with information about the actions of others prompts social comparison that can significantly influence behavior), social pressures (encouragement or discouragement from others is a powerful social force that can influence individual behavior), and social triggers (cues in the environment can motivate people to take certain actions and have powerful effects on purchasing behavior).
The results of this study and experience gained from the implementation of these interventions will be used to inform new versions of a larger trial intervention to be tested in new patient cohorts in a rapid cycle framework.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study arms leverage two strategies that the investigators think will be particularly effective at improving adherence and may be even more effective when used in tandem. Patients in some arms will be asked to select an adherence partner: another person who can help them adhere to their medication regimen. The investigators will contact this adherence partner and ask them to officially accept this role and provide guidance of their choosing as to how they can help the patient adhere. In addition, patients in some arms will receive an alert whenever two full days pass without their GlowCap being opened (i.e. 48 hours of non-adherence). This alert will encourage them to begin taking their medication again. The design allows for some patients to have both an adherence partner and to receive alerts after 48 hours of non-adherence. In these arms, the adherence partner would also receive the alert after 48 hours of non-adherence. This introduces a two-by-two design.
Subjects would spend 6 months in their randomly assigned treatment, and the investigators will compare adherence of subjects in each of the arms to one another.
The investigators plan to track daily adherence of patients to a prescribed chronic disease drug using a new technology that electronically monitors when a pill bottle has been opened. In our control condition, patients will be monitored but not be provided with any reminders, adherence information, or inclusion of friend of family member to help them adhere to their medication. Our four additional treatments will either: (1) email the patient after 48 hours of non-adherence; (2) allow the patient to select friend or family member to encourage medication adherence; (3) email the patient, as well as patient-selected friends or family members after 48 hours of non-adherence; or (4) provide the patient with a daily email, text message, or phone call reminder to take the pill.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
This arm will use GlowCaps to have their adherence tracked with no additional modifications:
Arm 1. Control group no modifications
Electronic Pill Bottle tracking
Electronic Pill Bottle tracking
All 4 groups will use the GlowCaps, a remote monitoring bottle, to take their statin medications
Feedback group
This arm will use GlowCaps to have their adherence tracked with the following modifications:
Arm 2. Feedback group participants will receive an adherence message after 48 hours of not using the GlowCaps
Electronic Pill Bottle tracking; Adherence Messaging
Electronic Pill Bottle tracking
All 4 groups will use the GlowCaps, a remote monitoring bottle, to take their statin medications
Adherence Messaging
Some arms will receive adherence messages if they have not used the Glowcap bottles for 2 of the last 3 days.
Adherence partner group
This arm will use GlowCaps to have their adherence tracked with the following modifications:
Arm 3. Adherence partner group participants will designate a family member or friend who will serve as an adherence partner, encouraging adherence of the patient
Electronic Pill Bottle tracking; Social Influence
Electronic Pill Bottle tracking
All 4 groups will use the GlowCaps, a remote monitoring bottle, to take their statin medications
Social Influence
Some arms will select their own adherence feedback partner who will provide support in taking their medication as scheduled.
Adherence partner along with feedback
This arm will use GlowCaps to have their adherence tracked with the following modifications:
Arm 4. Adherence partner along with feedback group participants will designate a family member or friend who will serve as an adherence partner, encouraging adherence of the patient, both the patient and partner will receive a message after 48 hours of not using the GlowCaps
Electronic Pill Bottle tracking; Adherence Messaging; Social Influence
Electronic Pill Bottle tracking
All 4 groups will use the GlowCaps, a remote monitoring bottle, to take their statin medications
Adherence Messaging
Some arms will receive adherence messages if they have not used the Glowcap bottles for 2 of the last 3 days.
Social Influence
Some arms will select their own adherence feedback partner who will provide support in taking their medication as scheduled.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electronic Pill Bottle tracking
All 4 groups will use the GlowCaps, a remote monitoring bottle, to take their statin medications
Adherence Messaging
Some arms will receive adherence messages if they have not used the Glowcap bottles for 2 of the last 3 days.
Social Influence
Some arms will select their own adherence feedback partner who will provide support in taking their medication as scheduled.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* experienced an AMI and have been placed on a once-a-day statin and have a medication adherence ratio (MPR) that is less than 80%.
* access to internet to create an account on Way to Heath.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Judd B Kessler, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Palmer MJ, Machiyama K, Woodd S, Gubijev A, Barnard S, Russell S, Perel P, Free C. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database Syst Rev. 2021 Mar 26;3(3):CD012675. doi: 10.1002/14651858.CD012675.pub3.
Kessler JB, Troxel AB, Asch DA, Mehta SJ, Marcus N, Lim R, Zhu J, Shrank W, Brennan T, Volpp KG. Partners and Alerts in Medication Adherence: A Randomized Clinical Trial. J Gen Intern Med. 2018 Sep;33(9):1536-1542. doi: 10.1007/s11606-018-4389-7. Epub 2018 Mar 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1C1CMS331009-01-00
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
817167
Identifier Type: -
Identifier Source: org_study_id